These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8660255)

  • 1. Limitation of infarct size by myocardial ischemic preconditioning.
    Van Winkle DM
    Basic Res Cardiol; 1996; 91(1):38-40. PubMed ID: 8660255
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward the heart of ischemic preconditioning.
    Dekker LR
    Cardiovasc Res; 1998 Jan; 37(1):14-20. PubMed ID: 9539853
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C.
    Downey JM; Cohen MV; Ytrehus K; Liu Y
    Ann N Y Acad Sci; 1994 Jun; 723():82-98. PubMed ID: 8030927
    [No Abstract]   [Full Text] [Related]  

  • 4. Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine.
    Miura T; Iimura O
    Cardiovasc Res; 1993 Jan; 27(1):36-42. PubMed ID: 8458029
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide, nitrates and ischaemic preconditioning.
    Rakhit RD; Edwards RJ; Marber MS
    Cardiovasc Res; 1999 Aug; 43(3):621-7. PubMed ID: 10690333
    [No Abstract]   [Full Text] [Related]  

  • 6. Preconditioning: markers vs. epiphenomena.
    Downey JM; Cohen MV
    Basic Res Cardiol; 1996; 91(1):35-7. PubMed ID: 8660254
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
    Mei DA; Nithipatikom K; Lasley RD; Gross GJ
    J Mol Cell Cardiol; 1998 Jun; 30(6):1225-36. PubMed ID: 9689596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for a mediator or effector of myocardial preconditioning: do KATP channels meet the requirements?
    Gross GJ; Mei DA; Schultz JJ; Mizumura T
    Basic Res Cardiol; 1996; 91(1):31-4. PubMed ID: 8660253
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning.
    Miura T; Suzuki K; Shimamoto K; Iimura O
    Basic Res Cardiol; 1996; 91(6):425-32. PubMed ID: 8996627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.
    Tanno M; Tsuchida A; Nozawa Y; Matsumoto T; Hasegawa T; Miura T; Shimamoto K
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):345-52. PubMed ID: 10710117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning slows ischemic metabolism and limits myocardial infarct size.
    Reimer KA; Vander Heide RS; Jennings RB
    Ann N Y Acad Sci; 1994 Jun; 723():99-115. PubMed ID: 8030928
    [No Abstract]   [Full Text] [Related]  

  • 14. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
    Bugge E; Ytrehus K
    Cardiovasc Res; 1995 Mar; 29(3):401-6. PubMed ID: 7781014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine and preconditioning revisited.
    Miura T; Tsuchida A
    Clin Exp Pharmacol Physiol; 1999 Feb; 26(2):92-9. PubMed ID: 10065327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
    McCully JD; Uematsu M; Parker RA; Levitsky S
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.
    Kersten JR; Schmeling TJ; Pagel PS; Gross GJ; Warltier DC
    Anesthesiology; 1997 Aug; 87(2):361-70. PubMed ID: 9286901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine and the anti-infarct effects of preconditioning.
    Downey JM; Liu GS; Thornton JD
    Cardiovasc Res; 1993 Jan; 27(1):3-8. PubMed ID: 8458028
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase.
    Kitakaze M; Node K; Minamino T; Komamura K; Funaya H; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
    Circulation; 1996 Feb; 93(4):781-91. PubMed ID: 8641008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.
    Yao Z; Gross GJ
    Circulation; 1994 Mar; 89(3):1229-36. PubMed ID: 8124811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.